Analysis of Antidiabetic Adverse Drug Reaction (ADR) at Puskesmas X Wonogiri Regency

Inandha Dewi; Sherley Anindia Putri; Inaratul Rizkhy Hanifah

Abstract

Antidiabetic drugs are used in the long term and have the potential for side effects or Adverse Drug Reaction (ADR), but how their prevalence and probability have not been widely studied. The purpose of this study was to determine the incidence rate of ADR, especially glibenclamide, metformin and insulin in primary care and how the probability is.

The type of research is an observational, descriptive non-analytic study, prospective data collection using questionnaires that have been tested for validity and reality. The number of samples used in this study was 120 respondents. The data were analyzed univariately by percentage of ADR events, and probability analysis was performed using the Naranjo algorithm.

The results showed that as many as 46 (38.3%) respondents experienced ADR. The types of ADR events in the form of nausea, drowsiness, dizziness, weakness, and tremor were 32.6%, 30.4%, 17.4%, 15.2%, and 3.3%. Glibenclamide causes manifestations of tremor, weakness, nausea, drowsiness in the categories of probable, doubtful, probable, probable. The use of metformin manifestations in the form of weakness, nausea, drowsiness, and dizziness in the categories of doubtful, possible, probable, and probable. The combination of Glibenclamide and Metformin manifests in the form of weakness, nausea, drowsiness, and dizziness in the categories of possible, probable, probable, and probable. Insulin manifestations in the form of weakness in the probable category.

Keywords: Adverse Drug Reaction;, Diabetes Melltus;, Anti-diabetes Mellitus Drug

References

[1] Yosmar R, Putri Inanta N, Yelly D, et al. (2018) Studi Prospektif Adverse Drug Reactions (ADRS) Obat Hipoglikemik Oral Terhadap Pasien Diabetes Mellitus Tipe 2 di Suatu Rumah Sakit, Padang (A Prospective Study On Adverse Drug Reactions (Adrs) Of Oral Hypoglycemic Agents Among Type 2 Diabetes Patients in. Jurnal Sains Farmasi & Klinis 5(3): 169–175. Available at: http://jsfk.ffarmasi.unand.ac.id.
[2] Emelda A, Wati A, Yulismayanti B, et al. (2022) Uji Toksisitas Ekstrak Etanol Batang Kayu Wole Woe Terhadap Larva Artemia salina Leach Menggunakan Metode Brine Shrimp Lethality Test (BSLT) (Toxicity Test of Ethanol Extract of Wole Woe Stem against Averhoa bilimbi L . Using Brine Shrimp Lethality Test ( BSLT ) Method ) Laboratorium Biofarmasi dan Farmakologi , Fakultas Farmasi , Universitas Muslim Indonesia , Makassar. 14(2): 168–173.
[3] Maharani NE, .dr S and Ardiyanto BF (2018) Hubungan Obesitas Dan Aktivitas Fisik Dengan Kejadian Diabetes Mellitus Tipe 2 Di Puskesmas Wonogiri I. Jurnal Manajemen Informasi dan Administrasi Kesehatan (JMIAK) 1(1). DOI: 10.32585/jmiak.v1i1.124.
[4] Hardianto D (2020). Jurnal Bioteknologi dan Biosains Indonesia7 ( Telaah Komperhensif Diabetes Melitus: Klasifikasi, Gejala, Diagnosis, Pencegahan, dan Pengobatan).
[5] Tampa’i R, Sumombo J, Hariyadi H, et al. (2021) Gambaran Drug Related Problems (DRPs) pada Pasien Diabetes Melitus Tipe 2 di Puskesmas Tuminting. Jurnal Kefarmasian Indonesia 11(1): 49–55. DOI: 10.22435/jki.v11i1.3499.
[6] Rusli (2018). In: Farmasi Rumah Sakit dan Klinik. Pertama. Jakarta: KEMENKES RI 2018. 151–154.
[7] Saravan, K., Manna, P.K., Mohanta, G.P., dan Manavalan R (2011) No Title. Jornal of Pharmacy Research 4(10)(A Study of Adverse Drug Reaction on Drug Use in The Management of Type 2 Diabetic Mellitus): 3394–3395.
[8] Joddy Sutama Putra R, Achmad A and Rachma Pramestutie H (2017) Kejadian Efek Samping Potensial Terapi Obat Anti Diabetes Pada Pasien Diabetes Melitus Berdasarkan Algoritme Naranjo. Pharmaceutical Journal of Indonesia 2(2): 45–50. DOI: 10.21776/ub.pji.2017.002.02.3.
[9] Asha Annisa Nur Azwarini, 2Fetri Lestari 3Tati Nurhayati (2019) Studi Kejadian Efek Samping Obat Antidiabetes Berdasarkan Algoritma Naranjo pada Pasien Prolanis di Puskesmas Sukajadi Kota Bandung. Prosiding Farmasi.
[10] Dwi Aulia Ramdini , Lilik Koernia Wahidah , Dwi Atika, Evaluasi Rasionalitas Penggunaan Obat Diabetes Melitus Tipe 2 pada Pasien Rawat Jalan di Puskesmas Pasir Sakti, 2019 , Jurnal Farmasi Lampung vol 9 No 1 Juni 2020.
[11] Fibra Milita, Sarah Handayani, Bambang Setiaji, Kejadian Diabetes Mellitus Tipe II pada Lanjut Usia di Indonesia (Analisis Riskesdas 2018), Jurnal Kedokteran dan Kesehatan, Vol. 17, No. 1, Januari 2021 ISSN : 0216 – 3942 Website : https://jurnal.umj.ac.id/index.php/JKK
[12] Raden Joddy Sutama Putra, Anisyah Achmad , Hananditia Rachma P,2017, Kejadian Efek Samping Potensial Terapi Obat Anti Diabetes Pasien Diabetes Melitus Berdasarkan Algoritma Naranjo, Pharmaceutical Journal of Indonesia 2(2) 45-50
[13] Badan POM RI, 2020, Modul Farmakovigilan Dasar, Badan PengawasObatdan Makanan- Japan International Cooperation Agency
[14] Nazhipah Isnani, Muliyani, 2018, Studi Farmakovigilans Obat Antidiabetes pada Pasien Rawat Jalan DM tipe ii di RSD Dr.H.Moch.Ansari Saleh, JIIS Jurnal Ilmiah Ibnu Sina

Author Biographies

Sherley Anindia Putri, Fakulty of Pharmacy Setia Budi University

Pharmacology, clinical and social pharmacy department

Inaratul Rizkhy Hanifah, Faculty of Pharmacy Setia Budi University

Peneliti bidang Pharmacologi, Clinical dan Social Pharmacy Department